Literature DB >> 30817554

Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.

David J Collett1, Hinne Rakhorst1, Peter Lennox1, Mark Magnusson1, Rodney Cooter1, Anand K Deva1.   

Abstract

BACKGROUND: With breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) now accepted as a unique (iatrogenic) subtype of ALCL directly associated with textured breast implants, we are now at a point where a sound epidemiologic profile and risk estimate are required. The aim of this article is to provide a comprehensive and up-to-date global review of the available epidemiologic data and literature relating to the incidence, risk, and prevalence of BIA-ALCL.
METHODS: All current literature relating to the epidemiology of BIA-ALCL was reviewed. Barriers relating to sound epidemiologic study were identified, and trends relating to geographical distribution, prevalence of breast implants, and implant characteristics were analyzed.
RESULTS: Significant barriers exist to the accurate estimate of both the number of women with implants (denominator) and the number of cases of BIA-ALCL (numerator), including poor registries, underreporting, lack of awareness, cosmetic tourism, and fear of litigation. The incidence and risk of BIA-ALCL have increased dramatically from initial reports of 1 per million to current estimates of 1/2,832, and is largely dependant on the "population" (implant type and characteristics) examined and increased awareness of the disease.
CONCLUSIONS: Although many barriers stand in the way of calculating accurate estimates of the incidence and risk of developing BIA-ALCL, steady progress, international registries, and collegiality between research teams are for the first time allowing early estimates. Most striking is the exponential rise in incidence over the last decade, which can largely be explained by the increasingly specific implant subtypes examined-driven by our understanding of the pathologic mechanism of the disease. High-textured high-surface area implants (grade 4 surface) carry the highest risk of BIA-ALCL (1/2,832).

Entities:  

Mesh:

Year:  2019        PMID: 30817554     DOI: 10.1097/PRS.0000000000005567

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  38 in total

1.  Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.

Authors:  Peter G Cordeiro; Paola Ghione; Andy Ni; Qunying Hu; Nivetha Ganesan; Natasha Galasso; Ahmet Dogan; Steven M Horwitz
Journal:  J Plast Reconstr Aesthet Surg       Date:  2020-01-20       Impact factor: 2.740

Review 2.  Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Mark W Clemens; Ryan C DeCoster; Berry Fairchild; Alexander A Bessonov; Fabio Santanelli di Pompeo
Journal:  Semin Plast Surg       Date:  2019-10-17       Impact factor: 2.314

3.  The First Confirmed Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Hawai'i.

Authors:  Nicholas Yim; Fereydoun Parsa; Paul Faringer
Journal:  Hawaii J Health Soc Welf       Date:  2019-11

4.  Trends in Breast Augmentation Research: A Bibliometric Analysis.

Authors:  CholSik Ri; Jiang Yu; JiaXin Mao; MuXin Zhao
Journal:  Aesthetic Plast Surg       Date:  2022-06-02       Impact factor: 2.326

5.  Boomerang latissimus dorsi flap in total breast reconstruction: report of three cases.

Authors:  Myeong Jae Kang; Tae Hyun Park; Jeong Yeop Ryu; Byeongju Kang; Jeeyeon Lee; Ho Yong Park; Jung Dug Yang; Joon Seok Lee
Journal:  Gland Surg       Date:  2022-01

Review 6.  New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Paul Ionescu; Florence Vibert; Shanti Amé; Carole Mathelin
Journal:  Eur J Breast Health       Date:  2021-10-04

7.  Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support.

Authors:  Serena Oliveri; Giulia Ongaro; Ilaria Durosini; Giuseppe Curigliano; Gabriella Pravettoni
Journal:  Breast Cancer Res Treat       Date:  2020-03-31       Impact factor: 4.872

8.  Breast Implant Safety: an Overview of Current Regulations and Screening Guidelines.

Authors:  Cayla D McKernan; Joshua Vorstenbosch; Jacqueline J Chu; Jonas A Nelson
Journal:  J Gen Intern Med       Date:  2021-05-23       Impact factor: 5.128

9.  Comparing the Antimicrobial Effect of Silver Ion-Coated Silicone and Gentamicin-Irrigated Silicone Sheets from Breast Implant Material.

Authors:  Fadi Heno; Ziv Azoulay; Boris Khalfin; Hillary A Craddock; Eldad Silberstein; Jacob Moran-Gilad; Hanna Rapaport
Journal:  Aesthetic Plast Surg       Date:  2021-05-26       Impact factor: 2.326

10.  Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.

Authors:  Jonas A Nelson; Stefan Dabic; Babak J Mehrara; Peter G Cordeiro; Joseph J Disa; Andrea L Pusic; Evan Matros; Joseph H Dayan; Robert J Allen; Michelle Coriddi; Thais O Polanco; Meghana G Shamsunder; Itay Wiser; Monica Morrow; Ahmet Dogan; Michele R Cavalli; Elizabeth Encarnacion; Meghan E Lee; Colleen M McCarthy
Journal:  Ann Surg       Date:  2020-09-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.